Search

Your search keyword '"Hide, Michihiro"' showing total 236 results

Search Constraints

Start Over You searched for: Author "Hide, Michihiro" Remove constraint Author: "Hide, Michihiro" Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
236 results on '"Hide, Michihiro"'

Search Results

1. Definition, acronyms, nomenclature, and classification of angioedema (DANCE): AAAAI, ACAAI, ACARE, and APAAACI DANCE consensus

2. A Core Outcome Set for Efficacy of Acute Treatment of Hereditary Angioedema

4. Enhancing evidence-informed policymaking in medicine and healthcare: stakeholder involvement in the Commons Project for rare diseases in Japan

5. The international WAO/EAACI guideline for the management of hereditary angioedema – The 2021 revision and update

8. Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials

13. Summary of the current status of clinically diagnosed cases of Schnitzler syndrome in Japan

15. The Bruton’s Tyrosine Kinase Inhibitor Remibrutinib Exhibits No Impact on Serum Immunoglobulin Levels: Insights from Chronic Spontaneous Urticaria (P10-6.018)

16. Safety of Remibrutinib Across Immune-mediated Diseases Supports Development in Multiple Sclerosis (P8-6.015)

18. Executive summary: Japanese guidelines for atopic dermatitis (ADGL) 2021

20. Prevalence of immune-related adverse events and anti-tumor efficacy following immune checkpoint inhibitor therapy in Japanese patients with various solid tumors

22. Survey of hereditary angioedema episodes and quality of life impairment through a patient-participatory registry

24. Efficacy of Remibrutinib in Patients With Chronic Spontaneous Urticaria With or Without Prior Exposure to Biologics in the Phase 3 REMIX-1 and REMIX-2 Studies

25. CRUSE®—An innovative mobile application for patient monitoring and management in chronic spontaneous urticaria

29. Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials

31. The practice of active patient involvement in rare disease research using ICT: experiences and lessons from the RUDY JAPAN project

33. A concept for integrated care pathways for atopic dermatitis—A GA2LEN ADCARE initiative

34. Time Course of Priming Effect of TF Inducers on Synergistic TF Expression and Intra-Cellular Gap Formation of Human Vascular Endothelial Cells via the Extrinsic Coagulation Cascade

37. ISID1357 - Construction of the atopic dermatitis sweat function registry (ADSF Registry) for sweating disturbance in atopic dermatitis evaluated by automatic assessment for skin microstructure and sweating.

38. Remibrutinib: A Novel BTKi in Development for MS With a Favorable Safety Profile in Various Autoimmune Disorders (P7-3.015)

40. Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials

41. Efficacy and safety of lanadelumab in Japanese patients with hereditary angioedema: A phase 3 multicenter, open‐label study.

42. Safety, efficacy, and pharmacokinetics of icatibant treatment in Japanese pediatric patients with hereditary angioedema: A phase 3, open‐label study.

43. English version of Japanese guidance for biologics in treating atopic dermatitis.

46. Exploring biomarkers to predict clinical improvement of atopic dermatitis in patients treated with dupilumab (B‐PAD study)

48. Summary of the current status of clinically diagnosed cases of Schnitzler syndrome in Japan

50. Epidemiology, Management, and Treatment Access of Hereditary Angioedema in the Asia Pacific Region: Outcomes From an International Survey

Catalog

Books, media, physical & digital resources